Sort by

Send to

Choose Destination

Links from PubMed

Items: 12


Worldwide susceptibility rates of Neisseria gonorrhoeae isolates to cefixime and cefpodoxime: a systematic review and meta-analysis.

Yu RX, Yin Y, Wang GQ, Chen SC, Zheng BJ, Dai XQ, Han Y, Li Q, Zhang GY, Chen X.

PLoS One. 2014 Jan 31;9(1):e87849. doi: 10.1371/journal.pone.0087849. Review.


Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines.

Dowell D, Tian LH, Stover JA, Donnelly JA, Martins S, Erbelding EJ, Pino R, Weinstock H, Newman LM.

Am J Public Health. 2012 Jan;102(1):148-55. doi: 10.2105/AJPH.2011.300283.


An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.

Patel AL, Chaudhry U, Sachdev D, Sachdeva PN, Bala M, Saluja D.

Indian J Med Res. 2011 Oct;134:419-31. Review.


Antimicrobial resistant gonorrhea in Atlanta: 1988-2006.

Dionne-Odom J, Tambe P, Yee E, Weinstock H, del Rio C.

Sex Transm Dis. 2011 Aug;38(8):780-2. doi: 10.1097/OLQ.0b013e318214e306.


Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006.

Mainous AG 3rd, Diaz VA, Matheson EM, Gregorie SH, Hueston WJ.

Public Health Rep. 2011 May-Jun;126(3):354-60.


Cephalosporin Resistance in Neisseria gonorrhoeae.

Bala M, Sood S.

J Glob Infect Dis. 2010 Sep;2(3):284-90. doi: 10.4103/0974-777X.68537.


Population dynamics of Neisseria gonorrhoeae in Shanghai, China: a comparative study.

Tazi L, PĂ©rez-Losada M, Gu W, Yang Y, Xue L, Crandall KA, Viscidi RP.

BMC Infect Dis. 2010 Jan 21;10:13. doi: 10.1186/1471-2334-10-13.


Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak.

Morris SR, Moore DF, Hannah PB, Wang SA, Wolfe J, Trees DL, Bolan G, Bauer HM.

J Clin Microbiol. 2009 Sep;47(9):2944-9. doi: 10.1128/JCM.01001-09.


Transcriptional profiling identifies the metabolic phenotype of gonococcal biofilms.

Falsetta ML, Bair TB, Ku SC, Vanden Hoven RN, Steichen CT, McEwan AG, Jennings MP, Apicella MA.

Infect Immun. 2009 Sep;77(9):3522-32. doi: 10.1128/IAI.00036-09.


The use of cephalosporins for gonorrhea: the impending problem of resistance.

Barry PM, Klausner JD.

Expert Opin Pharmacother. 2009 Mar;10(4):555-77. doi: 10.1517/14656560902731993 . Review.


Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates.

Jones RN, Fritsche TR, Sader HS.

Antimicrob Agents Chemother. 2008 Oct;52(10):3763-75. doi: 10.1128/AAC.00294-08.


Identification of TbpA residues required for transferrin-iron utilization by Neisseria gonorrhoeae.

Noto JM, Cornelissen CN.

Infect Immun. 2008 May;76(5):1960-9. doi: 10.1128/IAI.00020-08.

Items per page

Supplemental Content

Support Center